|
CN112220920A
|
|
Recombinant novel coronavirus vaccine composition
|
|
CN109666691A
|
|
EV71 vaccine preparation method and the vaccine prepared by this method
|
|
CN109750049A
|
|
The expression of 52 subtype protein of recombinant human papilloma virus
|
|
CN109750050A
|
|
The expression of 45 subtype protein of recombinant human papilloma virus
|
|
CN108130333A
|
|
I virus-like particle of recombinant poliovirus
|
|
CN108130332A
|
|
Recombinant poliovirus type III virus-like particle
|
|
CN106893730A
|
|
Restructuring human papilloma protein expression
|
|
CN106148359A
|
|
Recombinant human papilloma virus 33 subtype protein is expressed
|
|
CN104845985A
|
|
Recombinant human papilloma virus protein expression
|
|
CN104745606A
|
|
Coxsackie A16 type virus-like particles
|
|
CN110699366A
|
|
Expression of recombinant human papilloma virus 6 and 11 subtype protein pichia pastoris
|
|
CN104513826A
|
|
Human papilloma virus genes, vector, strain, and expression method thereof
|
|
CN103405386A
|
|
Liposome preparation method and method for preparing liposome adjuvant
|
|
CN103182081A
|
|
Preparation of rabies vaccine for human being
|
|
CN103182079A
|
|
Respiratory syncytial virus vaccine and preparation method thereof
|
|
CN103182078A
|
|
Rotavirus vaccine and preparation method thereof
|
|
CN102559615A
|
|
Preparation method of EV71 vaccine and vaccine prepared by preparation method
|
|
CN102526722A
|
|
Rabies vaccine for human beings
|
|
CN102443060A
|
|
Anti-HPV (human papilloma virus) antibody and preparation method and application thereof
|
|
CN101857870A
|
|
HPV58 L1 gene, vector, strain and expression method
|
